Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes [4]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 1, 2007, Pages 253-254

  Miura, Junnosuke ^a,c   Yamamoto, Yasuhiko ^b   Osawa, Mari ^a   Watanabe, Takuo ^b   Yonekura, Hideto ^b   Uchigata, Yasuko ^a   Yamamoto, Hiroshi ^b   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; INSULIN; LYSINE DERIVATIVE; PENTOSIDINE; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ARGININE; DRUG DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BODY MASS; CORRELATION COEFFICIENT; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY DYSFUNCTION; LETTER; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; SEX RATIO; STATISTICAL SIGNIFICANCE; UPREGULATION; BLOOD; GLOMERULUS FILTRATION RATE; METABOLISM; MIDDLE AGED; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; ARGININE; DIABETES MELLITUS, TYPE 1; FEMALE; GLOMERULAR FILTRATION RATE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; REGRESSION ANALYSIS;

EID: 33847619668     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000251533.18013.67     Document Type: Letter

References (8)

1. Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest. 2001;108:251-258.
2. Sakurai S, Yonekura H, Yamamoto Y, Watanabe T, Tanaka N, Li H, Rahman AK, Myint KM, Kim CH, Yamamoto H The AGE-RAGE system and diabetic nephropathy. J Am Soc Nephrol. 2003;8(Suppl 3):S259-S263.
3. Miura J, Uchigata Y, Yamamoto Y, Takeuchi M, Sakurai S, Watanabe T, Yonekura H, Yamagishi S, Makita Z, Sato A, Omori Y, Yamamoto H, Iwamoto Y. AGE downregulation on monocyte RAGE expression and its association with diabetic complications in Type 1 diabetes. J Diab Comp. 2004;18:53-59.
4. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin J, Li H, Yasui K, Takeuchi M, Makita M, Takasawa S, Okamoto H, Watanabe T, Yamamoto H. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J. 2003;370:1097-1109.
5. Sakurai S, Yamamoto Y, Tamei H, Matsuki H, Obata KI, Hui L, Miura J, Osawa M, Uchigata Y, Iwamoto Y, Watanabe T, Yonekura H, Yamamoto H Development of an ELISA for esRAGE and its application to type 1 diabetic patients. Diabetes Res Clin Pract. 2006;73:150-165.
6. Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, Shoji T, Tamei H, Matsuki H, Sakurai S, Yamamoto Y, Yonekura H, Watanabe T, Yamamoto H, Nishizawa, Y. Plasma level of endogenous secretory receptor for advanced glycation endproducts (esRAGE) is associated with components of the metabolic syndrome and atherosclerotic arterial wall thickness. Arterioscler Thromb Vasc Biol. 2005;25:2587-2593.
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. : Ann Intern Med. 1999;130:461-470.
8. Katami N, Matsuhisa M, Kaneto H, Yamasaki Y. Endogenous secretory receptor for Advanced glycation End Product levels are inversely associated with HbA1c in type 2 diabetic patients. Diabetes Care. 2006;29:469.